Drug Trial Radar · NCT00613938
A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy.
Last checked: Nov 19, 2026Latest source record: May 9, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
901
Actual
Start
Feb 2008
Primary completion
Oct 2008
Study completion Oct 2008
Sponsor
- Lead sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Johnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- Collaborators
- Grünenthal GmbH
- First posted
- Feb 13, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effectiveness (level of pain control) and safety of the administration of 2 different dose levels of tapentadol (CG5503) compared with oxycodone and with placebo in subjects who have had a bunionectomy.
Conditions
- Arthralgia
- Bunion
- Hallux Valgus
- Pain
Interventions
Tapentadol (CG5503)Drug
50mg capsule q4-6 hrs for 3 days
Tapentadol (CG5503)Drug
75mg capsule q4-6 hrs for 3 days
oxycodoneDrug
10mg capsule q4-6 hrs for 3 days
placeboDrug
1 capsule q4-6 hrs for 3 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sum of Pain Intensity Difference Over 48 Hours (SPID48)Time frame: 48 hours
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Glendale, California
Site not named
Pasadena, Maryland
Site not named
Austin, Texas
Site not named
Houston, Texas
Site not named
San Antonio, Texas
Site not named
San Marcos, Texas
Site not named
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.